CVRx Inc. is a healthcare company in the USA that specializes in developing and producing minimally invasive neuromodulation solutions for patients with cardiovascular illnesses. The company's proprietary technology, Barostim, aims to utilize the brain's power to combat Autonomic Nervous System imbalances that lead to heart failure and other cardiovascular conditions. The primary source of revenue for CVRx Inc. is the US market.